SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Wilma Mankiller — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientWilma Mankiller
Date of birth1945-11-18
IdentifiersMRN HR-ML052-SYN-TD; SSN (made up) 000-52-4183
Document date1980-07-13
AuthorRena Hawkfeather-Lindqvist, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Review five weeks after thymectomy. [S]

History of Present Illness

Ms. Mankiller returns five weeks after a robotic thymectomy, with two nights in hospital and no postoperative weakness or breathing problem. The pathology showed thymic follicular hyperplasia and no thymoma. The port sites have healed, and she took acetaminophen, not anti-inflammatory medicines, for the pain. Her eyelids have not drooped for three weeks. She raised azathioprine to 100 mg daily after two weeks, as planned, by telephone. The blood tests planned for two, four and six weeks after starting azathioprine were not done: the orders were placed at this clinic, she was preparing for surgery, and no one followed them up. She has had no fever, sore throat, bruising or jaundice. She is back at work three days a week. Home blood pressure readings are about 118/76. [S]

ElementDetail
ThymectomyRobotic, five weeks ago; no thymoma; uneventful recovery
StrengthMG-ADL 2
Azathioprine100 mg daily for eight weeks; the early blood tests were missed
WorkThree days a week

Review of Systems

SystemResultFinding
EyesNegativeNo ptosis or double vision for three weeks
RespiratoryNegativeNo breathlessness; mild ache at the port sites, settling
ConstitutionalNegativeNo fever, sore throat or night sweats
IntegumentaryNegativeNo bruising, jaundice or rash
PsychiatricNegativeMood good; PHQ-2 score 0

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Pyridostigmine bromide 30 mg oral tablet, one tablet three times daily with meals as a trial; take 30 to 45 minutes before eatingOne tablet three times dailyOral route1980-03-09 to 1980-03-23completedS
Pyridostigmine bromide 60 mg oral tablet, one tablet four times daily while awake, 30 to 45 minutes before mealsOne tablet four times daily while awakeOral route1980-03-23 to 1980-10-12completedS
Prednisone 10 mg oral tablet, 10 mg each morning, rising by 10 mg each week to 40 mg each morning, then held at 40 mgOnce each morning; dose as directedOral route1980-03-23 to 1980-07-13completedS
Prednisone 5 mg oral tablet, tapering from 40 mg each morning by 5 mg every two to three weeksOnce each morning; dose as directedOral route1980-07-13activeS
Azathioprine 50 mg oral tablet, one tablet daily for two weeks, then two tablets daily, then three tablets (150 mg, about 2.3 mg/kg) dailyOnce daily; dose as directedOral route1980-05-04activeS
Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet daily with foodOne tablet daily with foodOral route1980-03-23activeS
Cholecalciferol (vitamin D3) 1000 units (0.025 mg) oral tablet, one tablet dailyOne tablet dailyOral route1980-03-23activeS
Sulfamethoxazole 800 mg / trimethoprim 160 mg oral tablet, one tablet three times a week, while prednisone is 20 mg or more with azathioprineOne tablet on Monday, Wednesday and FridayOral route1980-05-04 to 1980-10-05completedS
Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg painOne or two tablets up to three times daily as neededOral route1979-09-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1980-07-13Body height163cmS
1980-07-13Body weight64.8kgS
1980-07-13Body mass index (BMI) [Ratio]24.4kg/m2S
1980-07-13Systolic blood pressure124mm[Hg]S
1980-07-13Diastolic blood pressure80mm[Hg]S
1980-07-13Heart rate74/minS
1980-07-13Respiratory rate14/minS
1980-07-13Body temperature36.7CelS
1980-07-13Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1980-07-13Hemoglobin [Mass/volume] in Blood12.6g/dL11.6-15 g/dLNormalS
1980-07-13Leukocytes [#/volume] in Blood by Automated count6.210*3/uL4-11 10*3/uLNormalS
1980-07-13Platelets [#/volume] in Blood by Automated count25010*3/uL150-400 10*3/uLNormalS
1980-07-13Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1980-07-13Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
1980-07-13Creatinine [Mass/volume] in Serum or Plasma0.79mg/dL0.59-1.04 mg/dLNormalS
1980-07-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1975)/1.73 sq M101mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1980-07-13Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma26U/L7-45 U/LNormalS
1980-07-13Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L8-43 U/LNormalS
1980-07-13Forced vital capacity [Volume] Respiratory system3.4LLower limit of normal about 2.9 L for her age, sex and heightNormalS
1980-07-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 1980-07-13; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 124/80 mm Hg; weight 64.8 kg
ChestThree healed port sites on the right; lungs clear
EyesNo ptosis after one minute of upgaze
NeurologicalNeck and limb strength 5 of 5 without fatigue

Problems

ProblemClinical statusVerificationCodeProvenance
Drooping eyelids and double vision for six weeks, worse in the evening, with fatigable weakness of the arms and neck, tiring when chewing and a nasal voice after long talks; a disorder of the neuromuscular junction suspectedresolvedconfirmed H53.2S — Synthetic presenting problem, resolved at the second visit when antibodies and nerve testing established myasthenia gravis.
Generalized myasthenia gravis, acetylcholine receptor antibody positive, MGFA class IIa, without thymoma; synthetic modern detail linked to her documented myasthenia gravis of 1934activeconfirmed G70.00S — Synthetic antibody level, electrodiagnosis, class and treatment; the diagnosis less than a year after the crash, and recovery with Cherokee medicine people, surgery and drug therapy, are documented (D).
Autosomal dominant polycystic kidney disease (hereditary, as she has described it), with normal kidney function; to be stagedactiveconfirmed Q61.2S — The hereditary polycystic kidney disease is documented (D) from her later public account; its detection before the index date, and every value, are synthetic.
Recovery from major trauma in a head-on car crash last year: fractures of both legs, ribs and face, with many operations; walks independently, with a cane on rough groundactiveconfirmed Z87.81S — The crash, the operations and the injuries are documented (D); the current function is synthetic.
Long-term glucocorticoid therapy for myasthenia gravis, with monitoring of glucose, blood pressure, weight, bone health, mood, sleep, eyes and infectionactiveconfirmed Z79.52S — Synthetic treatment plan.
Azathioprine as steroid-sparing therapy, with blood count and liver test monitoringactiveconfirmed Z79.624S — Synthetic treatment plan.
Acquired absence of the thymus after robotic extended thymectomy for myasthenia gravis (pathology: thymic follicular hyperplasia, no thymoma)activeconfirmed Z90.89S — Synthetic: recorded after the thymectomy; the sources name surgery among her treatments without saying which.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyMG-ADL scoreEvery visitCompleted today2
ImagingForced vital capacityEvery visit while on dose changes and after thoracic surgeryCompleted today3.40 L
ExaminationMyasthenic crisis warning signsEvery visitCompleted todayNone after surgery
LaboratoryBlood count on azathioprineEvery one to two weeks for the first two months, then every three monthsCompleted todayHemoglobin 12.6 g/dL; white cells 6.2; platelets 250
LaboratoryLiver tests, creatinine, potassium and glucoseWith each blood count on azathioprine; potassium on trimethoprim-sulfamethoxazoleCompleted todayALT 26 and AST 24 U/L; creatinine 0.79 mg/dL; eGFR 101; potassium 4.3 mmol/L; glucose 96 mg/dL
LaboratoryEarly azathioprine blood tests missedTwo, four and six weeks after startingDeferredNot done, a deviation from the protocol: the orders were placed here, she was preparing for surgery an hour's drive away, and no one followed up. Today's tests at ten weeks show no toxicity, so no harm resulted, but a low white count could have gone unnoticed. Corrective action: standing orders at the Cherokee Nation clinic near her home, with a nurse call for each result
ExaminationBlood pressure and weightEvery visitCompleted today124/80 mm Hg; home about 118/76; weight 64.8 kg
Medication safetyPneumocystis prophylaxisWhile prednisone is 20 mg or more with azathioprineCompleted todayContinues; potassium 4.3 mmol/L
Medication safetyGlucocorticoid effectsEvery visitCompleted todaySleep shorter; weight up 3 kg since diagnosis; no infection
SurveyDepression screen (PHQ-2)At intervalsCompleted todayPHQ-2 score 0
ReferralThymectomyOnceCompleted todayDone five weeks ago; no thymoma
Self-managementLaboratory access close to homeEach blood testCompleted todayStanding orders placed at the Cherokee Nation clinic

Goal progress:

Guideline basis: Narayanaswami P, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology 2021;96(3):114-122 (2020); Sanders DB, et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 2016;87(4):419-425 (2016); Wolfe GI, et al. Randomized Trial of Thymectomy in Myasthenia Gravis (MGTX). N Engl J Med 2016;375(6):511-522 (2016); KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int 2025;107(2S):S1-S239 (2025)

Follow-up: Blood count and liver tests at the Cherokee Nation clinic in two and six weeks. Preventive visit in six weeks. Review here in three months. Next scheduled visit 1980-08-24: periodic adult preventive visit. [S]